Genocea Biosciences, Inc.
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response

Last updated:

Abstract:

Herpes Simplex Virus-2 (HSV-2) infection is a major health concern. The present disclosure provides, inter alia, certain highly effective vaccines and immunogenic compositions against HSV-2. The antigens can be used therapeutically or prophylactically.

Status:
Grant
Type:

Utility

Filling date:

3 Jan 2018

Issue date:

19 May 2020